Granules secures FTF status for CNS depressant generic
Granules said the sole FTF designation strengthens the company’s position in the complex generics segment and demonstrates its growing capabilities in developing and advancing complex, differentiated generic products for the U.S market. File | Photo Credit: The Hindu Granules India has secured sole first-to-file (FTF) status for its abbreviated new drug application (ANDA) for Sodium…
Read More “Granules secures FTF status for CNS depressant generic” »